US2005221436A1PendingUtilityA1
Human neuropeptide Y-like G protein-coupled receptor
Est. expiryJul 6, 2020(expired)· nominal 20-yr term from priority
C07K 14/70571C07K 2319/00A61K 38/00
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Reagents which regulate human neuropeptide Y-like G protein-coupled receptor (NPY-like GPCR) protein and reagents which bind to human NPY-like GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, obesity, diabetes, anxiety, hypertension, cocaine withdrawal, congestive heart failure, memory enhancement, cardiac and cerebral vasospasm, pheochromocytoma, ganglioneuroblastoma, Huntington's disease, Alzheimer's disease, and Parkinson's disease.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . A purified polypeptide comprising the amino acid sequence shown in SEQ ID NO:2.
10 . The purified polypeptide of claim 9 which consists of the amino acid sequence of SEQ ID NO:2.
11 . A fusion protein comprising a polypeptide consisting of the amino acid sequence shown in SEQ ID NO:2.
12 - 43 . (canceled)Join the waitlist — get patent alerts
Track US2005221436A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.